Gene Logic and deSciner enter into a partnership to create 'Genomics Gateway'
10 Oct 2008, 1534 Hrs

Add comment          Mail          Print          Write to Editor

Gaithersburg/Leicester, Oct 10 (ANI/Business Wire India): Gene Logic has entered into a Strategic Alliance with deScinerT Business Network to create an interactive genomics information resource.

Both organizations will work together to create a unique knowledge resource in genomics called 'Genomics Gateway'. The vision of this partnership is to present applications of genomics in pursuit of improved and affordable healthcare and therapeutics.

The Gateway will feature leading scientists, developments and progress in this area through webinars, interactive interviews, and blogs amongst other vehicles.

The Gateway will be featured as new sections on the OBBeC(r) Biotech portal powered by deScinerT and Gene Logic's thought leadership forum.

"We are extremely delighted to be working with Gene Logic to incorporate such rich knowledge resource into OBBeC(r) Portal," said Tim El-Sheikh, Managing Director and CEO of deScinerT Business Network.

"We always strive to provide our worldwide readers with high quality and informative content from leading scientists and businesses from around the globe, discussing strategic issues and best practices in biotechnology, Bio-IT and healthcare sectors, all through a single online interface," addd Tim.

Anu Acharya, CEO, Gene Logic said, "We have a very strong corporate social responsibility program through which we reach out to our community. Genomics over the years has been defined and re-defined and we are now seeing exciting applications of genomics in the biotech sector. As a leader in the genomics space, we are pleased to partner with deScinerT to present the latest in the genomics and discovery space through various programs we have planned."

Ashwin Sivakumar, Ph.D, Director Marketing and Alliances, Gene Logic said, "State-of-the-art technologies like Genotyping, Differential Gene Expression, Genome Wide Association, SNPs et cetera have contributed immensely to global biomarker discovery programs as we all continue our pursuit for improved and affordable therapeutics. This alliance with deScinerT is a first of its kind partnership where we have broken traditional barriers to feature pioneering work of the genomics community and present news relating to advancements in this sector." (ANI)